Personalized Cardiovascular Disease Risk Mitigation via Longitudinal Inverse Classification

• URL: http://arxiv.org/abs/2011.08254v1
• Date: Mon, 16 Nov 2020 20:23:01 GMT
• Title: Personalized Cardiovascular Disease Risk Mitigation via Longitudinal Inverse Classification
• Authors: Michael T. Lash and W. Nick Street
• Abstract summary: Cardiovascular disease (CVD) is a serious illness affecting millions world-wide and is the leading cause of death in the US. Recent years have seen tremendous growth in the area of personalized medicine, a field of medicine that places the patient at the center of the medical decision-making and treatment process. Many CVD-focused personalized medicine innovations focus on genetic biomarkers, which provide person-specific CVD insights at the genetic level, but do not focus on the practical steps a patient could take to mitigate their risk of CVD development.
• Score: 3.5255730400158756
• License: http://arxiv.org/licenses/nonexclusive-distrib/1.0/
• Abstract: Cardiovascular disease (CVD) is a serious illness affecting millions world-wide and is the leading cause of death in the US. Recent years, however, have seen tremendous growth in the area of personalized medicine, a field of medicine that places the patient at the center of the medical decision-making and treatment process. Many CVD-focused personalized medicine innovations focus on genetic biomarkers, which provide person-specific CVD insights at the genetic level, but do not focus on the practical steps a patient could take to mitigate their risk of CVD development. In this work we propose longitudinal inverse classification, a recommendation framework that provides personalized lifestyle recommendations that minimize the predicted probability of CVD risk. Our framework takes into account historical CVD risk, as well as other patient characteristics, to provide recommendations. Our experiments show that earlier adoption of the recommendations elicited from our framework produce significant CVD risk reduction.

Related papers

• A Joint Representation Using Continuous and Discrete Features for Cardiovascular Diseases Risk Prediction on Chest CT Scans [12.652540031719571]
  We propose a novel joint representation that integrates discrete quantitative biomarkers and continuous deep features extracted from chest CT scans. Our method substantially improves CVD risk predictive performance and offers individual contribution analysis of each biomarker.
  arXiv  Detail & Related papers  (2024-10-24T10:06:45Z)
• Integrating Deep Learning with Fundus and Optical Coherence Tomography for Cardiovascular Disease Prediction [47.7045293755736]
  Early identification of patients at risk of cardiovascular diseases (CVD) is crucial for effective preventive care, reducing healthcare burden, and improving patients' quality of life. This study demonstrates the potential of retinal optical coherence tomography ( OCT) imaging combined with fundus photographs for identifying future adverse cardiac events. We propose a novel binary classification network based on a Multi-channel Variational Autoencoder (MCVAE), which learns a latent embedding of patients' fundus and OCT images to classify individuals into two groups: those likely to develop CVD in the future and those who are not.
  arXiv  Detail & Related papers  (2024-10-18T12:37:51Z)
• Petal-X: Human-Centered Visual Explanations to Improve Cardiovascular Risk Communication [1.4613744540785565]
  This work describes the design and implementation of Petal-X, a novel tool to support clinician-patient shared decision-making. Petal-X relies on a novel visualization, Petal Product Plots, and a tailor-made global surrogate model of SCORE2, whose fidelity is comparable to that of the GSCs used in clinical practice.
  arXiv  Detail & Related papers  (2024-06-26T18:48:50Z)
• Feasibility of Identifying Factors Related to Alzheimer's Disease and Related Dementia in Real-World Data [56.7069469207376]
  In total, we extracted 477 risk factors in 10 categories from 537 studies. Genetic testing for AD/ADRD is still not a common practice and is poorly documented in both structured and unstructured EHRs. Considering the constantly evolving research on AD/ADRD risk factors, literature mining via NLP methods offers a solution to automatically update our knowledge map.
  arXiv  Detail & Related papers  (2024-02-03T18:17:19Z)
• SurvLatent ODE : A Neural ODE based time-to-event model with competing risks for longitudinal data improves cancer-associated Deep Vein Thrombosis (DVT) prediction [68.8204255655161]
  We propose a generative time-to-event model, SurvLatent ODE, which parameterizes a latent representation under irregularly sampled data. Our model then utilizes the latent representation to flexibly estimate survival times for multiple competing events without specifying shapes of event-specific hazard function. SurvLatent ODE outperforms the current clinical standard Khorana Risk scores for stratifying DVT risk groups.
  arXiv  Detail & Related papers  (2022-04-20T17:28:08Z)
• COVID-Net US: A Tailored, Highly Efficient, Self-Attention Deep Convolutional Neural Network Design for Detection of COVID-19 Patient Cases from Point-of-care Ultrasound Imaging [101.27276001592101]
  We introduce COVID-Net US, a highly efficient, self-attention deep convolutional neural network design tailored for COVID-19 screening from lung POCUS images. Experimental results show that the proposed COVID-Net US can achieve an AUC of over 0.98 while achieving 353X lower architectural complexity, 62X lower computational complexity, and 14.3X faster inference times on a Raspberry Pi. To advocate affordable healthcare and artificial intelligence for resource-constrained environments, we have made COVID-Net US open source and publicly available as part of the COVID-Net open source initiative.
  arXiv  Detail & Related papers  (2021-08-05T16:47:33Z)
• COVID-Net CXR-S: Deep Convolutional Neural Network for Severity Assessment of COVID-19 Cases from Chest X-ray Images [74.77272804752306]
  We introduce COVID-Net CXR-S, a convolutional neural network for predicting the airspace severity of a SARS-CoV-2 positive patient based on a CXR image of the patient's chest. We leveraged transfer learning to transfer representational knowledge gained from over 16,000 CXR images from a multinational cohort of over 15,000 patient cases into a custom network architecture for severity assessment. The proposed COVID-Net CXR-S has potential to be a powerful tool for computer-aided severity assessment of CXR images of COVID-19 positive patients.
  arXiv  Detail & Related papers  (2021-05-01T14:15:12Z)
• SDF-Bayes: Cautious Optimism in Safe Dose-Finding Clinical Trials with Drug Combinations and Heterogeneous Patient Groups [84.63561578944183]
  This paper proposes a novel Bayesian design, SDF-Bayes, for finding the maximum tolerated dose (MTD) of a drug in a clinical trial. Rather than the conventional principle of escalating or de-escalating the current dose of one drug, SDF-Bayes proceeds by cautious optimism. Extensive experiments based on both synthetic and real-world datasets demonstrate the advantages of SDF-Bayes over state of the art DC trial designs.
  arXiv  Detail & Related papers  (2021-01-26T18:59:26Z)
• An explainable XGBoost-based approach towards assessing the risk of cardiovascular disease in patients with Type 2 Diabetes Mellitus [1.761604268733064]
  Cardiovascular Disease (CVD) is an important cause of disability and death among individuals with Diabetes Mellitus (DM) The aim of the present study is to develop and evaluate an explainable personalized risk prediction model for the fatal or non-fatal CVD incidence in T2DM individuals.
  arXiv  Detail & Related papers  (2020-09-14T12:19:10Z)
• Predicting Mortality Risk in Viral and Unspecified Pneumonia to Assist Clinicians with COVID-19 ECMO Planning [26.25177784899079]
  Respiratory complications due to coronavirus disease COVID-19 have claimed tens of thousands of lives in 2020. Many cases escalate from Severe Acute Respiratory Syndrome (SARS-CoV-2) to viral pneumonia to acute respiratory distress syndrome (ARDS) to death. Extracorporeal membranous oxygenation (ECMO) is a life-sustaining oxygenation and ventilation therapy that may be used for patients with severe ARDS when mechanical ventilation is insufficient to sustain life.
  arXiv  Detail & Related papers  (2020-06-02T19:30:29Z)

This list is automatically generated from the titles and abstracts of the papers in this site.

This site does not guarantee the quality of this site (including all information) and is not responsible for any consequences.